Publishing research using ab134162? Please let us know so that we can cite the reference in this datasheet.
ab134162 has been referenced in 5 publications.
- Pirie-Shepherd SR et al. Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients. PLoS One 12:e0179561 (2017). PubMed: 28727782
- Abdalla Z et al. Loss of epithelial markers is an early event in oral dysplasia and is observed within the safety margin of dysplastic and T1 OSCC biopsies. PLoS One 12:e0187449 (2017). PubMed: 29216196
- Guo X et al. 5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells. Sci Rep 7:4859 (2017). PubMed: 28687750
- Kerk SA et al. 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 23:2516-2527 (2017). PubMed: 27780858
- Sapra P et al. Long-term tumor regression induced by an antibody-drug conjugate that targets 5T4, an oncofetal antigen expressed on tumor-initiating cells. Mol Cancer Ther 12:38-47 (2013). IHC-P . PubMed: 23223830